TSS
SNOA icon

Two Sigma Securities’s Sonoma Pharmaceuticals SNOA Stock Holding History

Two Sigma Securities’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-766
Closed -$3.25K – 3568
2024
Q2 		$3.25K Buy
766
+92
+14% +$327 ﹤0.01% 2873
2024
Q1 		$2.24K Buy
+674
New +$2.18K ﹤0.01% 2858
2023
Q4 		– Sell
-1,926
Closed -$29.7K – 3538
2023
Q3 		$29.7K Sell
1,926
-676
-26% -$13.2K ﹤0.01% 2527
2023
Q2 		$55.7K Buy
+2,602
New +$53.5K ﹤0.01% 2384
2022
Q2 		– Sell
-1,906
Closed -$153K – 2802
2022
Q1 		$153K Buy
+1,906
New +$138K 0.01% 1768
2019
Q2 		– Sell
-58
Closed -$10K – 2390
2019
Q1 		$10K Buy
+58
New +$8.77K ﹤0.01% 1731
2018
Q4 		– Sell
-72
Closed -$19K – 2772
2018
Q3 		$19K Buy
+72
New +$26.2K ﹤0.01% 2450

Other funds holding SNOA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Two Sigma Securities's SNOA Position: Q3 2024 in Review

Two Sigma Securities sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2024, closing a stake of 766 shares — an estimated $3.25K sold.

Two Sigma Securities first reported a position in SNOA in Q3 2018 and held it in 7 quarters. The position peaked at $153K in Q1 2022. 14 funds tracked by Wall St. Rank hold SNOA as of Q3 2024.

  • Two Sigma Securities reported no remaining Sonoma Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Securities sold 766 Sonoma Pharmaceuticals shares in Q3 2024, an estimated $3.25K.
  • Two Sigma Securities first reported a position in Sonoma Pharmaceuticals in Q3 2018 and held it in 7 quarters.
  • Two Sigma Securities's Sonoma Pharmaceuticals position peaked at $153K in Q1 2022.
  • 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.